Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Flavien Aké"'
Autor:
Alpha Oumar Diallo, Heidi M Soeters, Issaka Yameogo, Guetawendé Sawadogo, Flavien Aké, Clément Lingani, Xin Wang, Andre Bita, Amadou Fall, Lassana Sangaré, Rasmata Ouédraogo-Traoré, Isaïe Medah, Brice Bicaba, Ryan T Novak, MenAfriNet Consortium
Publikováno v:
PLoS ONE, Vol 12, Iss 11, p e0187466 (2017)
Historically, Neisseria meningitidis serogroup A (NmA) caused large meningitis epidemics in sub-Saharan Africa. In 2010, Burkina Faso became the first country to implement a national meningococcal serogroup A conjugate vaccine (MACV) campaign. We ana
Externí odkaz:
https://doaj.org/article/4d71a18415f74b83a367c15f9753d434
Autor:
Dinanibè Kambiré, Heidi M Soeters, Rasmata Ouédraogo-Traoré, Isaïe Medah, Lassana Sangare, Issaka Yaméogo, Guetawendé Sawadogo, Abdoul-Salam Ouédraogo, Soumeya Hema-Ouangraoua, Lesley McGee, Velusamy Srinivasan, Flavien Aké, Malika Congo-Ouédraogo, Soufian Sanou, Absatou Ky Ba, Ryan T Novak, Chris Van Beneden, MenAfriNet Consortium
Publikováno v:
PLoS ONE, Vol 11, Iss 11, p e0166384 (2016)
Following introduction of Haemophilus influenzae type b vaccine in 2006 and serogroup A meningococcal conjugate vaccine in 2010, Streptococcus pneumoniae (Sp) became the leading cause of bacterial meningitis in Burkina Faso. We describe bacterial men
Externí odkaz:
https://doaj.org/article/1475d7ce0f7a451eb1a28d6382119f62
Autor:
Ryan T. Novak, Heidi M Soeters, Cynthia Hatcher, Jenny A. Walldorf, Alpha Oumar Diallo, Isaïe Medah, Robert L. Zoma, Jaymin C. Patel, Terri B. Hyde, Ludovic Kambou, Félix Tarbangdo, Brooke Noel Aksnes, Mohamed F Jalloh, Imran Mirza, Sansan Hien, Sylvain F. Nkwenkeu, Soukeynatou Fall, Flavien Aké, Cesaire Ky
Publikováno v:
Vaccine
Highlights • Caregivers were motivated to vaccinate their children against measles and meningitis. • Motivations were driven by vaccine communication and perceived disease protection. • Health workers were trusted sources of vaccine information
Autor:
Bertrand Meda, Edouard Betsem, Lesley McGee, Seydou Yaro, Flavien Aké, Félix Tarbangdo, Berthe Marie Njanpop-Lafourcade, Brice Bicaba, Jennifer C. Moïsi, Cynthia G. Whitney, Srinivasan Velusamy, Alain Gervaix, Lassané Kaboré, Chris A. Van Beneden, Soumeya Ouangraoua, Bradford D Gessner, Tolulope Adebanjo
Publikováno v:
The Journal of Infectious Diseases
Background Burkina Faso, a country in Africa’s meningitis belt, introduced 13-valent pneumococcal conjugate vaccine (PCV13) in October 2013, with 3 primary doses given at 8, 12 and 16 weeks of age. To assess whether the new PCV13 program controlled
Autor:
Kalifa Ouattara, Susanna Schmink, Xin Wang, Barnabé Sanon, Issaka Yaméogo, Michael W. Spiller, Yvette Donnou, Flavien Aké, Mamadou Tamboura, Frederic Acho Aboua, Lassana Sangaré, Mahamadou Sanou, Jaymin C. Patel, Paul A. Kristiansen, Idrissa Kamaté, Tanga Kiemtore, Augustin Kyetega, Guetawendé Sawadogo, Félix Tarbangdo, Brice Bicaba, Ryan T. Novak, Hermann Somlare, Absatou Ky Ba, Nadav Topaz, Gerard Komonsira Dioma, Malika Congo-Ouédraogo, Rasmata Ouédraogo-Traoré, Sarah Mbaeyi, Emmanuel Sampo, Kambire Dinanibe
Publikováno v:
The Lancet. Infectious Diseases
Summary Background In the first 2 years after a nationwide mass vaccination campaign of 1–29-year-olds with a meningococcal serogroup A conjugate vaccine (MenAfriVac) in Burkina Faso, carriage and disease due to serogroup A Neisseria meningitidis w
Autor:
Brice Bicaba, Absatou Ky Ba, Malika Congo-Ouédraogo, Soumeya Ouangraoua, Isaïe Medah, Guetawendé Sawadogo, Srinivasan Velusamy, Heidi M Soeters, Abdoul-Salam Ouédraogo, Chris A. Van Beneden, Cynthia G. Whitney, Issaka Yaméogo, Lesley McGee, Flavien Aké, Rasmata Ouédraogo-Traoré, Dinanibè Kambiré, Lassana Sangaré
Publikováno v:
Vaccine
Highlights • From 2011 to 2017, Burkina Faso had 20 pneumococcal meningitis clusters of ≥ 5 cases per district/week. • Clusters had a maximum weekly incidence of 7 cases and a maximum duration of 4 weeks. • Most clusters occurred prior to 13-
Autor:
Assétou Y Dembélé, Alpha Oumar Diallo, Clement Lingani, Adodo Yao Sadji, Mahamat A Acyl, Yibayiri Osee Sanogo, Xin Wang, Heidi M Soeters, Haoua Tall, Ryan T. Novak, Goumbi Kadadé, Jeni T Vuong, Jennifer C. Moïsi, Félix Tarbangdo, Brice Bicaba, Flavien Aké, Marietou F Paye, Olivier Ronveaux, Sarah Mbaeyi, Souleymane Sakande, Christelle Nikiema, Alain Poy
Publikováno v:
J Infect Dis
Background The MenAfriNet Consortium supports strategic implementation of case-based meningitis surveillance in key high-risk countries of the African meningitis belt: Burkina Faso, Chad, Mali, Niger, and Togo. We describe bacterial meningitis epidem
Autor:
Brice Bicaba, Lassana Sangaré, Lesley McGee, Soumeya Ouangraoua, Flavien Aké, Velusamy Srinivasan, Isaïe Medah, Rasmata Ouédraogo-Traoré, Chris A. Van Beneden, Dinanibè Kambiré, Malika Congo-Ouédraogo, Abdoul-Salam Ouédraogo, Cynthia G. Whitney, Absatou Ky Ba, Issaka Yaméogo, Heidi M Soeters, Ryan T. Novak, Guetawendé Sawadogo
Publikováno v:
J Infect Dis
Background In 2013, Burkina Faso introduced 13-valent pneumococcal conjugate vaccine (PCV13) into the routine childhood immunization program, to be administered to children at 8, 12, and 16 weeks of age. We evaluated the impact of PCV13 on pneumococc
Autor:
Jenny A. Walldorf, Isaïe Medah, Akshaya Krishnaswamy, Terri B. Hyde, Hermann Badolo, Robert L. Zoma, Guetawendé Sawadogo, Moumouni Nikiema, Ludovic Kambou, Sylvain F. Nkwenkeu, Félix Tarbangdo, Imran Mirza, Heidi M Soeters, Alpha Oumar Diallo, Cynthia Hatcher, Ange B Bationo, Jaymin C. Patel, Arnaud Ouedraogo, Ryan T. Novak, Flavien Aké, Romeo Ouili, Kathleen Wannemuehler
Publikováno v:
The Journal of Infectious Diseases. 220:S233-S243
Background After successful meningococcal serogroup A conjugate vaccine (MACV) campaigns since 2010, Burkina Faso introduced MACV in March 2017 into the routine Expanded Programme for Immunization schedule at age 15–18 months, concomitantly with se
Autor:
Souleymane Sakande, Oumou Coulibaly, Ado Bwaka, Alpha Oumar Diallo, Christelle Nikiema, Mahamat A Acyl, Jennifer C. Moïsi, Maman Zaneidou, Alain Poy, Kadidja Gamougame, Aboubacar N'diaye, Olivier Ronveaux, Brice Bicaba, Souleymane Coulibaly, Haoua Tall, Katya Fernandez, Fati Sidikou, Adodo Yao Sadji, Félix Tarbangdo, Berthe-Marie Njanpop-Lafourcade, Sarah Mbaeyi, Heidi M Soeters, Ryan T. Novak, Andre Bita, Jeni Vuong, Rasmata Ouédraogo-Traoré, Flavien Aké, Clement Lingani
Publikováno v:
The Journal of Infectious Diseases. 220:S155-S164
Background The MenAfriNet consortium was established in 2014 to support implementation of case-based meningitis surveillance in 5 countries in the meningitis belt of sub-Saharan Africa: Burkina Faso, Chad, Mali, Niger, and Togo. Assessing surveillanc